Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Refractory ascites: definition, pathogenesis and treatment

G Laffi1, G La Villa, M Pinzani

  • 1Istituto di Clinica Medica Generale e Terapia Medica II, Università degli Studi di Firenze.

Annali Italiani Di Medicina Interna : Organo Ufficiale Della Societa Italiana Di Medicina Interna
|January 1, 1993
PubMed
Summary

Refractory ascites in cirrhosis is difficult to treat, often caused by vasodilation and kidney dysfunction. Current treatments like paracentesis and LeVeen shunts have limitations, prompting research into new therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serological assessment of PRO-C16 (type XVI collagen formation) reflects intestinal fibrostenotic strictures in patients with crohn's disease.

BMC gastroenterology·2025
Same author

Hypogammaglobulinemia and severe infections in Multiple Sclerosis patients on anti-CD20 agents: A multicentre study.

Multiple sclerosis and related disorders·2024
Same author

Pregnancy effect on disease activity in women with multiple sclerosis treated with cladribine.

Journal of neurology·2024
Same author

Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2022
Same author

Elevated ectodomain of type 23 collagen is a novel biomarker of the intestinal epithelium to monitor disease activity in ulcerative colitis and Crohn's disease.

United European gastroenterology journal·2020
Same author

Dimethyl fumarate-induced lymphocyte count drop is related to clinical effectiveness in relapsing-remitting multiple sclerosis.

European journal of neurology·2020

Area of Science:

  • Hepatology
  • Nephrology
  • Gastroenterology

Background:

  • Refractory ascites affects 5% of cirrhosis patients, resisting standard diuretic and dietary therapy.
  • Pathogenesis involves arterial vasodilation, renal underfilling, and imbalances in vasoactive factors.
  • Impaired renal function exacerbates refractory ascites due to reduced renal perfusion and glomerular filtration.

Purpose of the Study:

  • To review the pathophysiology of refractory ascites.
  • To discuss current therapeutic options and their limitations.
  • To explore emerging experimental treatments for refractory ascites.

Main Methods:

  • Literature review of refractory ascites pathophysiology and treatment.
  • Analysis of current therapeutic strategies including paracentesis and LeVeen shunt.

Related Experiment Videos

  • Examination of experimental therapies such as ornipressin and thromboxane synthase inhibitors.

    • Main Results:

    • Refractory ascites is driven by complex hemodynamic and renal factors.
    • Paracentesis offers temporary relief but doesn't address underlying sodium retention.
    • LeVeen shunts provide longer control but carry risks of complications and occlusion.
    • Neither standard procedure improves patient survival.

    Conclusions:

    • Refractory ascites presents significant therapeutic challenges in cirrhosis.
    • Existing treatments are palliative and do not enhance survival.
    • Experimental therapies show promise in addressing the underlying mechanisms of refractory ascites.